Cargando…

Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study

BACKGROUND: A phase III multi-centre randomised trial (ROSEL) has been initiated to establish the role of stereotactic radiotherapy in patients with operable stage IA lung cancer. Due to rapid changes in radiotherapy technology and evolving techniques for image-guided delivery, guidelines had to be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hurkmans, Coen W, Cuijpers, Johan P, Lagerwaard, Frank J, Widder, Joachim, van der Heide, Uulke A, Schuring, Danny, Senan, Suresh
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631491/ https://www.ncbi.nlm.nih.gov/pubmed/19138400 http://dx.doi.org/10.1186/1748-717X-4-1

Ejemplares similares

Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose
por: Schuring, Danny, et al.
Publicado: (2008)

Quality assurance of four-dimensional computed tomography in a multicentre trial of stereotactic body radiotherapy of centrally located lung tumours
por: Lambrecht, Marie, et al.
Publicado: (2018)

Same-day consultation, simulation and lung Stereotactic Ablative Radiotherapy delivery on a Magnetic Resonance-linac
por: Palacios, Miguel A., et al.
Publicado: (2022)

Coroner’s Investigation.—Suspected Poisoning: Case of Mary E. Rosell, of Binghamton, N. Y.
Publicado: (1860)

A critical review of recent developments in radiotherapy for non-small cell lung cancer
por: Baker, Sarah, et al.
Publicado: (2016)

The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer
por: Tetar, Shyama U., et al.
Publicado: (2020)

A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4–10 brain metastases
por: Hartgerink, Dianne, et al.
Publicado: (2021)

A network score-based metric to optimize the quality assurance of automatic radiotherapy target segmentations
por: Rodríguez Outeiral, Roque, et al.
Publicado: (2023)

Verifying 4D gated radiotherapy using time-integrated electronic portal imaging: a phantom and clinical study
por: van Sörnsen de Koste, John R, et al.
Publicado: (2007)

The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
por: Dahele, Max, et al.
Publicado: (2011)

Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer
por: Verstegen, Naomi E., et al.
Publicado: (2016)

Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial
por: Zindler, Jaap D., et al.
Publicado: (2017)

Quality assurance of radiotherapy in the ongoing EORTC 22042–26042 trial for atypical and malignant meningioma: results from the dummy runs and prospective individual case Reviews
por: Coskun, Mehtap, et al.
Publicado: (2013)

Precise film dosimetry for stereotactic radiosurgery and stereotactic body radiotherapy quality assurance using Gafchromic™ EBT3 films
por: Wen, Ning, et al.
Publicado: (2016)

Assessment of Delivery Quality Assurance for Stereotactic Radiosurgery With Cyberknife
por: Li, Jun, et al.
Publicado: (2021)

Reproducibility of target volumes generated using uncoached 4-dimensional CT scans for peripheral lung cancer
por: van der Geld, Ylanga G, et al.
Publicado: (2006)

Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy
por: Finazzi, Tobias, et al.
Publicado: (2020)

Recommendations of the Working Party on Financing CERN Budgets
Publicado: (1977)

Adoption of Stereotactic Body Radiotherapy for Stage IA Non–Small Cell Lung Cancer Across the United States
por: Holmes, Jordan A., et al.
Publicado: (2017)

Quality assurance for the EORTC 22071–26071 study: dummy run prospective analysis
por: Fairchild, Alysa, et al.
Publicado: (2014)

A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer
por: Underberg, René WM, et al.
Publicado: (2006)

A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan
por: Takeda, Kayoko, et al.
Publicado: (2020)

Quality Assurance and Commissioning of an Infrared Marker-Based Patient Positioning System for Frameless Extracranial Stereotactic Radiotherapy
por: Gupta, Tejpal, et al.
Publicado: (2007)

Matched linac stereotactic radiotherapy: An assessment of delivery similarity and distributive patient‐specific quality assurance feasibility
por: Goodall, Simon K, et al.
Publicado: (2022)

Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk
por: Schneiders, Famke L., et al.
Publicado: (2023)

Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases
por: van Sörnsen de Koste, John R., et al.
Publicado: (2021)

Radiofrequency ablation vs. stereotactic body radiotherapy for stage IA non-small cell lung cancer in nonsurgical patients
por: Li, Ming, et al.
Publicado: (2021)

A quality assurance method with submillimeter accuracy for stereotactic linear accelerators
por: Grimm, Jimm, et al.
Publicado: (2010)

Part II: Specific Recommendations for Quality Assurance
por: Giroud, F., et al.
Publicado: (1998)

Choice of Treatment for Stage IA Non-small Cell Lung Cancer Patients Ineligible for Surgery: Ablation or Stereotactic Body Radiotherapy?
por: Liang, Long, et al.
Publicado: (2020)

(18)F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study
por: Wiegman, Erwin M., et al.
Publicado: (2011)

Comment on Rosell-Cardona et al. Dietary Spray-Dried Porcine Plasma Reduces Neuropathological Alzheimer’s Disease Hallmarks in SAMP8 Mice. Nutrients 2021, 13, 2369
por: Nifli, Artemissia-Phoebe
Publicado: (2021)

Evaluation and Performance of ArcCheck and Film using Gamma Criteria in Pre-treatment Quality Assurance of Stereotactic Ablative Radiotherapy
por: Ramachandran, Prabhakar, et al.
Publicado: (2017)

Evaluation of a complementary metal oxide semiconductor detector as a tool for stereotactic body radiotherapy plan quality assurance
por: Stepanek, Chris J., et al.
Publicado: (2023)

Parties and party leaders
por: Morse, Anson Daniel
Publicado: (1923)

Quantitative Magnetic Resonance Imaging for Biological Image-Guided Adaptive Radiotherapy
por: van Houdt, Petra J., et al.
Publicado: (2021)

Commissioning and quality assurance of a commercial stereotactic treatment‐planning system for extracranial IMRT
por: Wang, Lu, et al.
Publicado: (2006)

Quality assurance of Cyberknife robotic stereotactic radiosurgery using an angularly independent silicon detector
por: Alhujaili, Sultan Fahad, et al.
Publicado: (2018)

Technology‐driven research for radiotherapy innovation
por: Fiorino, Claudio, et al.
Publicado: (2020)

Significant tumor shift in patients treated with stereotactic radiosurgery for brain metastasis
por: Hessen, Eline D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_htlf1jo7i9h6r7342d6u2k8ao6